Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisolone plus vitamin D for primary minimal change nephropathy
2017-001206-16Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisolone in nephrosis and Idiopathic nephrotic syndrome (INS), sponsored by Aarhus University Hospital. Primary endpoints: Remission at 16 weeks and Time to remission. Started May 2017; status: completed.
02
Drugs
prednisolone
03
Conditions
nephrosisIdiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on 2017-001206-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001206-16.